Skip to content

Clinical trials

Phase 1/2 Leukemia, Lymphocytic, Chronic, B-Cell trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Lymphocytic, Chronic, B-Cell Phase: Phase 1/2 Country / region: Germany Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20032
20071
20101
20112
20152
20161
20182
20191
20201
20212
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Recruiting4
Active, not recruiting3
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fred Hutchinson Cancer Center3
German CLL Study Group3
AstraZeneca2
Celgene2
Genmab2
AbbVie1
Aptevo Therapeutics1
BeOne Medicines1
Genentech, Inc.1
Incyte Corporation1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Lymphocytic, Chronic, B-Cell20
Lymphoma, Non-Hodgkin7
Lymphoma, Mantle-Cell6
Lymphoma, Follicular5
Lymphoma, Large B-Cell, Diffuse5
Hodgkin Disease4
Precursor Cell Lymphoblastic Leukemia-Lymphoma4
Lymphoma, B-Cell, Marginal Zone3
Recurrence3
Waldenstrom Macroglobulinemia3

Trials

Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.